Safety and efficacy of olutasidenib treatment in elderly patients with relapsed/refractory mIDH1 acute myeloid leukemia

被引：0
|
作者：
De Botton, Stephane
Jonas, Brian Andrew
Ferrell, P. Brent
Chao, Mwe Mwe
Mims, Alice S.
机构：
[1] Inst Gustave Roussy, Villejuif, France
[2] Univ Calif Davis, Comprehens Canc Ctr, Sacramento, CA USA
[3] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[4] Rigel Pharmaceut Inc, South San Francisco, CA USA
[5] Ohio State Univ, Columbus, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6527
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment for Relapsed/Refractory Acute Myeloid Leukemia
    Thol, Felicitas
    Heuser, Michael
    HEMASPHERE, 2021, 5 (06): : E572
  • [22] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Bose, Prithviraj
    Vachhani, Pankit
    Cortes, Jorge E.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (03)
  • [23] Treatment of Relapsed/Refractory Acute Myeloid Leukemia
    Prithviraj Bose
    Pankit Vachhani
    Jorge E. Cortes
    Current Treatment Options in Oncology, 2017, 18
  • [24] Safety and efficacy of pracinostat in combination with gemtuzumab ozogamicin (PraGO) in patients with relapsed/refractory acute myeloid leukemia
    Abedin, Sameem M.
    Badar, Talha
    Gauger, Katelyn
    Michaelis, Laura C.
    Runaas, Lyndsey
    Carlson, Karen-Sue
    Murthy, G. S. Guru
    Atallah, Ehab
    LEUKEMIA RESEARCH, 2022, 123
  • [25] Improved Hematologic Recovery with Ivosidenib in Patients with mIDH1 Relapsed or Refractory MDS: Results from a Phase 1 Substudy
    Prince, Gabrielle T.
    Baratam, Praneeth
    Garcia-Manero, Guillermo
    Angiolillo, Anne
    Bhagnani, Tarun
    Vestin, Assaf
    Fathi, Amir T.
    BLOOD, 2024, 144 : 3226 - 3227
  • [26] Tosedostat for the treatment of relapsed and refractory acute myeloid leukemia
    DiNardo, Courtney D.
    Cortes, Jorge E.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (02) : 265 - 272
  • [27] Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia
    Wang, Li
    Xu, Jun
    Tian, Xiaolong
    Lv, Tingting
    Yuan, Guolin
    ACTA HAEMATOLOGICA, 2019, 141 (01) : 43 - 53
  • [28] Outcome of Refractory and Relapsed Patients with Acute Myeloid Leukemia
    Niederwieser, Dietger
    Krahl, Rainer
    Kahle, Christoph
    Scholl, Sebastian
    Wolf, Hans-Heinrich
    Cross, Michael
    Hegenbart, Ute
    Peter, Norma
    Niederwieser, Christian
    Florschuetz, Axel
    Reifenrath, Kolja F. B.
    Zojer, Niklas
    Junghanss, Christian
    Sayer, Herbert
    Schmidt, Volker
    Maschmeyer, Georg
    Hochhaus, Andreas
    Fischer, Thomas
    Al-Ali, Haifa Kathrin
    Heinicke, Thomas
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 106 - 106
  • [29] RETRACTED: Analysis of the Clinical Efficacy of Azacytidine plus Venetoclax in the Treatment of Elderly Patients with Relapsed Refractory Acute Myeloid Leukemia (Retracted Article)
    Wang, Wei
    Luo, Quanfang
    Chen, Qinpin
    Pang, Aiping
    Fang, Kuiyan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [30] Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study
    Kensuke Usuki
    Hiroshi Handa
    Ilseung Choi
    Takahiro Yamauchi
    Hiroatsu Iida
    Tomoko Hata
    Shoichi Ohwada
    Noriko Okudaira
    Kota Nakamura
    Sakura Sakajiri
    International Journal of Hematology, 2019, 110 : 654 - 664
12345